What Changed
Price Move History
- Daily moves over 5%
- 46 67 sessions, October 27, 2025 to October 30, 2026
- Largest daily move
- -66.7% close of February 19, 2026
- 1-year change
- -72.1% closing prices, October 27, 2025 to October 30, 2026
- 1-month change
- -25.3% closing prices, September 16, 2026 to October 30, 2026
Company Description
LGNDZ declined 72.1% in the 12 months to October 30, 2026. The last closing price was $0.0017.
For FY2025, Ligand Pharms CVR reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.
This page collects what Stock Titan holds for LGNDZ, including price data, SEC filings, insider trading activity, financial highlights, and short interest trends.
Stock Performance
Ligand Pharms CVR (LGNDZ) closed at $0.0017 on October 30, 2026. In the 12 months to October 30, 2026, the price lost 72.1%.
See what a $1,000 investment in LGNDZ was worth at its last close
LGNDZ Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Ligand Pharms CVR has filed 10 recent SEC filings, including 5 Form 144, 4 Form 4, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LGNDZ SEC filings →
Insider Radar
Insider selling at Ligand Pharms CVR over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Ligand Pharms CVR generated $268.1M in revenue in FY2025, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. The current ratio was 22.23, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Ligand Pharms CVR (LGNDZ) currently stands at 25 shares, representing 0.0% of the shares outstanding.
Days to Cover History
Days to cover for Ligand Pharms CVR (LGNDZ) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.